The development of live attenuated vaccines involves the attenuation, or weakening, of the pathogen in a laboratory setting. This process can be achieved through various methods, such as repeated culturing of the pathogen in non-human cells, which reduces its ability to cause disease in humans but still allows it to stimulate an immune response.
